Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Simon de Lusignan, Adam Meijer et al.|Eurosurveillance|2021Cited by 55
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysisFrank Sandmann, Marc Baguelin, Sibylle Bernard-Stoecklin et al.|Vaccine|2022Cited by 23
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021Esther Kissling, Marta Valenciano, Mariëtte Hooiveld et al.|Unknown|2021Cited by 2
Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance networkJohanna Young, Philippe Vanhems, Heather Mutch et al.|European Journal of Public Health|2023Cited by 2